Admission Date:  [**2200-11-10**]              Discharge Date:   [**2200-11-18**]   Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 10593**] Chief Complaint: shortness of breath  Major Surgical or Invasive Procedure: Thoracentesis [**2200-11-10**]   History of Present Illness: [**Age over 90 **] year old female that was brought to the ED tonight for shortness of breath.
A thoracentesis was performed and removed 1.5L.
The patient symptomatically improved and required lower oxygen requirements.
She was given IV vancomycin and cefepime for empiric antimicrobial coverage.
In the ED, initial VS were: Sinus tachycardia, 108, 125/76, 29, 5L NC .
Patient aware of her location and self but confused to time.
Pertinent Results: On admission: [**2200-11-10**] 07:05PM BLOOD WBC-15.6* RBC-5.88* Hgb-16.9* Hct-52.7* MCV-90 MCH-28.7 MCHC-32.0 RDW-14.0 Plt Ct-131* [**2200-11-10**] 07:05PM BLOOD Neuts-89.2* Lymphs-5.9* Monos-3.7 Eos-0.9 Baso-0.3 [**2200-11-10**] 07:05PM BLOOD PT-17.8* PTT-22.4 INR(PT)-1.6* [**2200-11-10**] 07:05PM BLOOD Glucose-394* UreaN-59* Creat-1.5* Na-138 K-5.5* Cl-95* HCO3-20* AnGap-29* [**2200-11-10**] 07:05PM BLOOD LD(LDH)-523* [**2200-11-10**] 07:05PM BLOOD proBNP-[**Numeric Identifier 1199**]* [**2200-11-10**] 07:05PM BLOOD cTropnT-0.03* [**2200-11-10**] 07:05PM BLOOD Calcium-9.6 Phos-6.2* Mg-2.2 [**2200-11-12**] 07:08AM BLOOD %HbA1c-10.8* eAG-263* [**2200-11-11**] 04:41AM BLOOD TSH-5.7* [**2200-11-11**] 08:25PM BLOOD Vanco-9.8* [**2200-11-10**] 07:25PM BLOOD Type-ART pO2-77* pCO2-31* pH-7.45 calTCO2-22 Base XS-0 [**2200-11-10**] 07:13PM BLOOD Glucose-339* Lactate-5.3* [**2200-11-11**] 12:18AM BLOOD O2 Sat-95 [**2200-11-11**] 12:18AM BLOOD freeCa-1.10* [**2200-11-11**] 01:15AM URINE Color-Yellow Appear-Hazy Sp [**Last Name (un) **]-1.017 [**2200-11-11**] 01:15AM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-300 Ketone-NEG Bilirub-NEG Urobiln-2* pH-5.0 Leuks-NEG [**2200-11-11**] 01:15AM URINE RBC-5* WBC-3 Bacteri-FEW Yeast-NONE Epi-1 [**2200-11-11**] 01:15AM URINE CastHy-64* [**2200-11-11**] 01:15AM URINE Hours-RANDOM UreaN-897 Creat-159 Na-10 K-74  On discharge: [**2200-11-17**] 07:00AM BLOOD WBC-11.7* RBC-4.65 Hgb-13.5 Hct-42.3 MCV-91 MCH-29.0 MCHC-31.9 RDW-14.6 Plt Ct-211 [**2200-11-14**] 08:30AM BLOOD PT-13.2* PTT-26.7 INR(PT)-1.2* [**2200-11-17**] 07:00AM BLOOD Glucose-157* UreaN-11 Creat-0.6 Na-138 K-4.3 Cl-100 HCO3-26 AnGap-16 [**2200-11-12**] 07:08AM BLOOD proBNP-3694* [**2200-11-17**] 07:00AM BLOOD Calcium-8.4 Phos-3.8 Mg-1.7 [**2200-11-16**] 06:30AM BLOOD Triglyc-183* HDL-29 CHOL/HD-6.0 LDLcalc-108 [**2200-11-12**] 06:51AM BLOOD Lactate-1.6  Pleural Fluid: [**2200-11-10**] 09:37PM PLEURAL WBC-299* RBC-179* Polys-34* Lymphs-16* Monos-0 Meso-2* Macro-18* Other-30* [**2200-11-10**] 09:37PM PLEURAL TotProt-3.8 LD(LDH)-115 Cholest-119 GRAM STAIN (Final [**2200-11-10**]):       1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
Immunohistochemical stains show that tumor cells stain positive for B72.3, [**Last Name (un) **]-31 (weak) and cytokeratin 7; cells are negative for CD15 (LeuM1), cytokeratin 20, TTF-1, mammoglobin, GCDFP, ER, PR and CDX2.
Immunostains for calretinin and WT-1 highlight background mesothelial cells.
Microbiology: Blood Culture, Routine (Final [**2200-11-16**]):       STAPHYLOCOCCUS, COAGULASE NEGATIVE.
Heterogeneous opacification in the left lung could be residual atelectasis or reexpansion edema and should be followed.
Thoracentesis was performed that removed 1.5L of fluid.
Patient was transitioned to ceftriaxone and azithromycin for empiric coverage for CAP and treated with 7 days of antibiotics.
Oxygen requirements were weaned and the patient was transferred on 2L on nasal cannula.
Discussion of therapeutic options for the pleural effusion was held, including possible options of chest tube drain and pleurodesis.
Prior to discharge, the option of performing a repeat thoracentesis to drain remaining fluid was discussed with the family.
On [**2200-11-17**], family meeting was held with the palliative care team to discuss goals of care and options for care at home vs extended care facility.
She will also be provided with medications to help with comfort, including morphine.
Patient was started on a baby aspirin and will remain on her simvastatin.
After thoracentesis and fluid resuscitation lactate improved to 4.1.
Received IV vancomycin and cefepime in the ED and was transitioned to ceftriaxone/azithromycin.
She was given conservative IV fluids prn for signs of volume depletion, including tachycardia to low 100s and low urine output.
#Hyperglycemia/DM type 2, uncontrolled, without complications: Patient with a history of diabetes and on glimepiride at home presenting with serum glucose of 394.
Patient was started on sliding scale insulin.
Hemoglobin A1c was 10.8.
Risks and benefits of oral agents for diabetes were discussed with family.
Because of the risks of hypoglycemia and her minimal po intake, the patient was not discharged on home oral hypoglycemics.
Left DP/PT present on Doppler but was not able to be obtained on the right.
# Bacteremia: Blood culture on arrival to ED [**2200-11-10**] grew GPCs in clusters; she was started on vancomycin empirically.
Vancomycin was discontinued after one day.
She may find symptomatic relief with anti-diarrheal agents such as loperamide.
She was given conservative IV fluids prn for volume depletion.
Although swallow therapist felt that there were no restrictions on her diet, she was kept on a soft dysphagia diet because the family requested it.
Medications on Admission: ALENDRONATE - 70 mg Tablet - 1 Tablet(s) by mouth weekly DONEPEZIL - 5 mg Tablet - 1 Tablet(s) by mouth once a day glimepiride 1 mg tab QD SIMVASTATIN - 10 mg Tablet - 1 Tablet(s) by mouth at bedtime   Discharge Medications: 1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Compression stockings Provide 1 pair of compression stockings 4. simvastatin 10 mg Tablet Sig: One (1) Tablet PO once a day.
The hospice team will provide your family with medications to keep you comfortable.
The following medication changes were made: 1) STOP glimepride 2) START aspirin 81mg daily 3) You may continue to take simvastatin 10mg daily 4) STOP alendronate  Followup Instructions: You will be cared for by a hospice team at home.
